90K status in stage I NSCLC tumors according to the clinicopathological features of patients
| Variable . | 90K low n (%) . | 90K high n (%) . | P . |
|---|---|---|---|
| Age (mean± SD, yr) | 63.8± 7.1 | 63.2± 6.3 | 0.72 |
| Sex | |||
| Male | 50 (96) | 17 (85) | 0.13 |
| Female | 2 (4) | 3 (15) | |
| Tumor differentiation | |||
| Well (G1) | 14 (27) | 6 (30) | 0.92 |
| Moderate (G2) | 20 (38) | 8 (40) | |
| Poor (G3) | 18 (35) | 6 (30) | |
| Histological type | |||
| SCCa | 25 (48) | 11 (55) | 0.90 |
| AD | 19 (36) | 6 (30) | |
| BAC | 4 (8) | 2 (10) | |
| LCC | 4 (8) | 1 (5) | |
| Tumor size | |||
| T1 | 12 (23) | 7 (35) | 0.37 |
| T2 | 40 (77) | 13 (65) | |
| Distant metastases | |||
| Present | 11 (21) | 12 (60) | 0.0038 |
| Absent | 41 (79) | 8 (40) |
| Variable . | 90K low n (%) . | 90K high n (%) . | P . |
|---|---|---|---|
| Age (mean± SD, yr) | 63.8± 7.1 | 63.2± 6.3 | 0.72 |
| Sex | |||
| Male | 50 (96) | 17 (85) | 0.13 |
| Female | 2 (4) | 3 (15) | |
| Tumor differentiation | |||
| Well (G1) | 14 (27) | 6 (30) | 0.92 |
| Moderate (G2) | 20 (38) | 8 (40) | |
| Poor (G3) | 18 (35) | 6 (30) | |
| Histological type | |||
| SCCa | 25 (48) | 11 (55) | 0.90 |
| AD | 19 (36) | 6 (30) | |
| BAC | 4 (8) | 2 (10) | |
| LCC | 4 (8) | 1 (5) | |
| Tumor size | |||
| T1 | 12 (23) | 7 (35) | 0.37 |
| T2 | 40 (77) | 13 (65) | |
| Distant metastases | |||
| Present | 11 (21) | 12 (60) | 0.0038 |
| Absent | 41 (79) | 8 (40) |
SCC, squamous cell carcinoma; AD, adenocarcinoma; BAC, bronchioloalveolar carcinoma; and LCC, large cell carcinoma.